{
    "code": "60001133",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001133",
    "time": "2022-10-28 03:56:08",
    "許可證字號": "衛部菌疫輸字第001133號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/07\/20",
    "發證日期": "109\/07\/20",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000113303",
    "中文品名": "杜避炎注射劑200毫克",
    "英文品名": "Dupixent solution for injection 200mg",
    "適應症": "1.異位性皮膚炎：可用於治療6歲(含)以上患有中度至重度異位性皮膚炎且對局部處方治療控制不佳或不適合使用該療法的病人。可併用或不併用局部皮質類固醇治療。\r\n2.氣喘：可作為12歲(含)以上患有嗜酸性白血球表現型或口服皮質類固醇依賴型之重度氣喘病人的附加維持治療(add-on maintenance therapy)。使用限制：不適用於緩解急性支氣管痙攣或重積性氣喘(status asthmaticus)。\r\n3.慢性鼻竇炎合併鼻瘜肉：可作為患有慢性鼻竇炎合併鼻瘜肉(CRSwNP)之成人病人在鼻內皮質類固醇治療下仍控制不佳的附加維持治療 (add-on maintenance therapy)。",
    "劑型": "230預充填式注射劑",
    "包裝": "100支以下盒裝 (1.14 ml pre-filled syringe with safety system) 1.14毫升預充填注射針筒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新療效(新適應症)",
    "監視期限": "114\/07\/20",
    "主成分略述": "dupilumab",
    "限制項目": "02輸　入 5E已執行國內臨床試驗",
    "申請商名稱": "1707201200  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "MFR0940000  Sanofi Winthrop Industrie",
            "製造廠廠址": "1051 BOULEVARD INDUSTRIEL, 76580 LE TRAIT, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "7770824858  台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FBE0085100  GENZYME FLANDERS BV",
            "製造廠廠址": "CIPALSTRAAT 8, 2440 GEEL, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0332000  REGENERON PHARMACEUTICALS INC.",
            "製造廠廠址": "81 COLUMBIA TURNPIKE RENSSELAER NY 12144 U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9250001500",
            "成分名稱": "dupilumab",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文使用手冊擬稿(clean)_Dupixent 200mg_PFS-S_HA comment-110-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001133&Seq=004&Type=9"
        },
        {
            "title": "中文仿單擬稿(clean)-Dupixent 200mg & 300mg_TWPI_C_USPI202005_HA comment-110-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001133&Seq=003&Type=9"
        },
        {
            "title": "001133-Dupixent 200mg_英文標籤-TFDA-109-08-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001133&Seq=003&Type=8"
        },
        {
            "title": "001133-Dupixent 200mg_英文外盒-TFDA-109-08-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001133&Seq=002&Type=8"
        },
        {
            "title": "001133-Dupixent 200mg_中文標籤紙卡-200mg yellow-109-08-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001133&Seq=001&Type=8"
        }
    ]
}